Biosynex signed a binding offer to acquire 100% of the stock in Avalun SAS, a company developing the Labpad in vitro diagnostic device that provides rapid biological test results from small sample volumes. Read more [...]
BIOSYNEX, which has established itself with the COVID-19 pandemic as a key player in decentralized biology, is highly complementary to AVALUN. Read more
BIOSYNEX was highlighted at ICASA 2019 in the context of the « community village », a platform for exchanges and listening between key populations and actors in the fight against AID. Read more
As the HIV Conference begins in Amsterdam and brings together policy makers, the pharmaceutical industry and many associations from around the world, the TV report shows an increase in the number of HIV-positive people in [...]
Biosynex has the great pleasure to invite you to a conference focusing on selftesting and new rapid test developments (multiplexing).
Come and meet the Biosynex team booth n°3E42 at MEDICA trade fair in Düsseldorf.
Join the Biosynex team at Medic West Africa exhibition in Lagos
The Biosynex team will be at the AACC 2018 meeting in Chicago
Meet the Biosynex team at AIDS 2018
Join the Biosynex team on stand 151
